OncoHost, a global leader in next-generation precision oncology dedicated to advancing personalized cancer therapy, announced today that it has been named a winner in the 2025 BIG Innovation Awards.
Histopathological evaluation of tumour specimens has long been essential in diagnosing breast cancer and guiding clinical ...
By integrating visual and textual data, Stanford's revolutionary AI model achieves unprecedented accuracy in outcome ...
Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, today announced that Germany's medical regulatory body, the Paul-Ehrlich-Institute (PEI), has ...
Hosted on MSN3h
Stanford Medicine's AI Model Accurately Predicts Cancer Prognoses, Treatment EfficacyThe model is the first of its kind to use multiple types of imaging and language-based data to assess a cancer patient's ...
Hosted on MSN8h
From cancer to diabetic retinopathy, how AIIMS is betting big on AI to aid in diagnosticsArogya Aarohan app & other AI-driven tools are being tested for early detection of diseases as part of Rs 300-cr initiative ...
Artificial intelligence (AI)-supported double-reading mammography is associated with a higher breast cancer detection ...
Companies from Johnson & Johnson to Eli Lilly, Amazon and Nvidia are announcing health-related deals at the JPMorgan Health ...
Welcome to the Novartis presentation at the 43rd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to introduce Vas Narasimhan, the CEO ...
A RECENT observational study has shown that AI can significantly enhance breast cancer detection rates in mammography ...
The Huntsman Cancer Institute's second mobile cancer screening clinic was opened on Monday. It will help provide screenings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback